Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Blog March 4, 2020
What CVS and Anthem Gained From The Centene-WellCare Deal
Blog March 3, 2020
The Year 2019 in Japanese Health Technology Assessment
Blog February 28, 2020
Humana Grows Senior Health Business with Latest Deals
Eleven potential blockbuster drugs offer hope, threaten budgets Eleven potential blockbuster drugs offer hope, threaten budgets
Blog February 10, 2020
Eleven potential blockbuster drugs offer hope, threaten budgets
First-in-class Tazverik launched for rare sarcoma, wider use will drive market value First-in-class Tazverik launched for rare sarcoma, wider use will drive market value
Blog February 6, 2020
First-in-class Tazverik launched for rare sarcoma, wider use will drive market value
Blog February 5, 2020
Cigna & Oscar Product Could Be New Disruptor in Small Group Market
Blog January 15, 2020
Top 10 Predictions for US Managed Markets in 2020 & Beyond
Blog January 13, 2020
Top 10 PBM Industry Macrotrends in 2019 & What to Expect in 2020
Benefits of HTA implementation in the Middle East and North Africa Benefits of HTA implementation in the Middle East and North Africa
Blog January 6, 2020
Benefits of HTA implementation in the Middle East and North Africa
The microbiome mystery: Gaining insights through data mining and analysis The microbiome mystery: Gaining insights through data mining and analysis
Blog December 16, 2019
The microbiome mystery: Gaining insights through data mining and analysis